| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |